KNOREX Ltd. Receives NYSE American Notification Regarding Delayed Annual Report Filing

KNOREX Ltd. announced on May 22, 2026, that it received a notice from NYSE Regulation on May 18, 2026, indicating non-compliance with continued listing standards due to a delayed filing of its annual report on Form 20-F for the fiscal year ended December 31, 2025. The company was granted an initial cure period until November 15, 2026, with a potential extension to May 15, 2027. Failure to file the report within these periods may lead to suspension and delisting procedures. The delinquency does not immediately impact the listing of the company's shares. KNOREX cited time constraints in compiling and reviewing the required information, including financial statements, as the reason for the delay. The company is working with its advisors to prepare and file the report within the initial cure period, though regaining compliance is not assured. KNOREX provides AI-driven advertising technology solutions.